Nafarelin is a GnRH agonist given as a nasal spray; in a six-month double-blind trial in 213 women with endometriosis it reduced disease extent at laparoscopy as much as oral danazol, with hot flashes rather than the adverse lipid changes seen with danazol.
fact added identity: CAS registry number 76932-56-4. · 2026-09-27 12:04 · somebody
fact added summary: Nafarelin is a GnRH agonist given as a nasal spray; in a six-month double-blind trial in 213 women with endometriosis it · 2026-09-27 12:04 · somebody
citation added pmid 2963213 cited as established: Nasal nafarelin was as effective as danazol for endometriosis (double-blind RCT) · 2026-09-27 12:04 · somebody
Negative findings
failure is information
Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.